INNOVENT BIOLOGICS INC financial statements, including revenue, expenses, and profit
The total revenue of 1801 for the last semiannual is 5.93 B HKD, and it's 38.54% higher compared to the previous semiannual. The net income of H2 24 is 323.26 M HKD.